3030-53-3Relevant academic research and scientific papers
The impact of graphene nano-plates on the behavior of novel conducting polyazomethine nanocomposites
Hussein, Mahmoud A.,El-Shishtawy, Reda?M.,Obaid, Abdullah Y.
, p. 9998 - 10008 (2017)
The aim of the current work was to synthesize a new series of polyazomethine/graphene nano-plate nanocomposites in the form of PAMs/GNPa-e. Different compositions were fabricated according to the percentage of GNP loading. The composites were f
Determination of free radical on polycrystal of 4,4′- bis(chloroacetyl)diphenylether: An ESR study
Ceylan, Yusuf,Usta, Ayhan,Usta, Keziban,Durmaz, Fatih,Co?kun, Ahmet
, p. 69 - 72 (2013)
4,4′-Bis(chloroacetyl)diphenylether was synthesized and its polycrystal form was produced. This polycrystal sample was irradiated by gamma rays (60Co) for 72 h. The ESR method was used to observe formation of free radical on the sample. ESR sig
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 51-52, (2012/04/10)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 49, (2010/11/03)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
DIARYL ETHERS
-
Page/Page column 25, (2010/11/05)
Compounds of the formula (I): including any possible stereoisomers thereof, or a pharmaceutically acceptable salt and/or solvate thereof, as well as pharmaceutical formulations and the use of compounds of formula I as HCV inhibitors.
Oxybis(4,1-phenylene(2-oxo-2,1-ethanediyl)) thiocyanate and its use as an antimicrobial agent
-
, (2008/06/13)
Oxybis(4,1-phenylene(2-oxo-2,1-ethanediyl)) thiocyanate is prepared by reacting diphenyl oxide with chloroacetyl chloride and reacting the intermediate formed thereby with potassium thiocyanate. The compound has antimicrobial utility.
Epoxy resins prepared from polyhydroxy-containing compounds
-
, (2008/06/13)
New polyhydroxy-containing compounds represented by the formula SPC1 Wherein A is --O-- or an alkylidene group having 1 to 4 carbon atoms, Y1, Y2, Y3 and Y4 are independently selected from --OH or SPC2 (wherein
